BCRX BioCryst Pharmaceuticals, Inc.: Accounting Value per Share
BioCryst (BCRX) specializes in developing orphan drugs, offering an affordable tablet form instead of injections, which ensures high profitability. The business model relies on outsourcing production and testing to maintain structural flexibility. This chart illustrates that the asset's market value is -1.78. Current growth is supported by sales of the unique drug Orladeyo, which stabilizes cash flows while new developments are being advanced.
biocryst.com - analytical breakdowns and key metrics (BCRX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:BioCryst Pharmaceuticals Inc - BCRX
Assessing asset quality requires analyzing the difference between the issuer's total assets and liabilities. This indicator measures the net shareholder equity by excluding debt load from the calculation. The trend in book value per share reveals periods of stagnation or growth in the capital base. For BioCryst (BCRX), this reflects resource stability during the scaling of the drug Orladeyo. Strategic partnerships with pharmacy chains directly impact the capitalization of these assets.
Competitors of BioCryst (BCRX)
Net Assets per Single Share Argenx (ARGX)|BioNTech Pharma (BNTX) - Accounting Value of a Share|Accounting Value per Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|ENGN - Book Value per Share|RAPT - Net Assets per Single Share|aerovatetx.com - Book Value per Share|ACRS (aclaristx.com) - Net Assets per Share|Net Assets per Single Share KYTX (Kyverna Therapeutics, Inc.)|Net Asset Value per Share Tiziana Life Sciences Ltd.|Book Value per Share CABA (Cabaletta Bio, Inc)|Accounting Value per Share VTYX (Ventyx Biosciences, Inc)|Net Assets per Single Share Theratechnologies Inc.|AVTX - Accounting Value of a Share|ELDN (Eledon Pharmaceuticals, Inc.) - Accounting Value per Share|AGEN: Net Asset Value per Share|Climb Bio, Inc. - Net Assets per Single Share|Net Assets per Share Zura Bio Ltd|aTyr Pharma, Inc. (ATYR) - Accounting Value per Share|Book Price of a Share Adagene Corp|Book Value per Share ImageneBio Inc (IMA)|Net Assets per Single Share shattucklabs.com (STTK)|Equillium - Book Value per Share|Connect Biopharma Holdings - Accounting Value per Share|Net Assets per Single Share Immunic Inc (IMUX)|Atara Biotherapeutics (ATRA) - Accounting Value of a Share|Accounting Value per Share inflarx.de|XFOR (X4 Pharmaceuticals Inc.) - Equity per Share|Net Assets per Single Share Adicet Bio Inc. ACET|Share Book Value Celularity Corp|INmune Bio, Inc. (INMB) - Book Value per Share|Accounting Value of a Share barinthusbio.com (BRNS)|Book Value per Share KZR (Kezar Life Sciences, Inc.)|SAB Biotherapeutics Inc. - Book Value per Share|Net Assets per Single Share Akari Therapeutics plc (AKTX)|ENLV: Accounting Value of a Share|QTTB (q32bio.com) - Net Assets per Single Share|geovax.com (GOVX) - Accounting Value per Share|EDSA (Edesa Biotech) - Book Value per Share|Book Value per Share iBio Inc (IBIO)|Carisma Therapeutics (CARM) - Accounting Value per Share|Accounting Value of a Share XTL Bio (XTLB)|Book Value per Share BOLT|HCW Biologics, Inc. - Net Assets per Share|APVO: Net Assets per Single Share|AIM: Accounting Value per Share|ADTX (aditxt.com) - Net Assets per Single Share|Accounting Value per Share GRI Bio Corporation|XRTX (XORTX Therapeutics Inc.) - Accounting Value per Share|Book Value per Share HIND|Net Assets per Single Share Revelation Biosciences, Inc. REVB|Equity per Share Indaptus Therapeutics Inc (INDP)|SCNI: Book Value per Share|Net Asset Value per Share CalciMedica Inc CALI|AFMD - Book Value per Share|ALLK - Net Assets per Single Share|hookipapharma.com - Book Value per Share|IGMS (IGM Biosciences) - Net Assets per Share|Net Assets per Single Share ITOS (iTeos)|Net Asset Value per Share Ocean Biomedical Corp|Book Value per Share TCBP (TC Biopharm)|Accounting Value per Share THRD (thirdharmonicbio.com)